← Leaderboards
Victor V Roschke
Theraly Fibrosis, Inc.
$3,411,790
Attributed
$3,411,790
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2017–20$2M$1.5M$1M$500K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$3,411,790 · 1
By mechanism
U44$3,411,790 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAlcohol AbuseAlcohol ConsequencesAlcohol EffectAlcoholsAnimal ModelAntibodiesApoptosisAssay DevelopmentBaseBindingCancer CellCellsCell TransformationCessation Of LifeCgmp ProductionChronicChronic PainChronic PancreatitisClinical DataClinical MaterialClinical ProtocolsClinical ResearchAbdominal Pain
Grant awards (3)
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis$1,498,190
U44 · FY2020 · AA · contact PI
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis$988,751
U44 · FY2018 · AA · contact PI
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis$924,849
U44 · FY2017 · AA · contact PI